A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: Study rationale and design

Journal of Cardiac Failure

Volumn 21, Issue 1, 2015, Pages 16-23

  Abraham, William T ^a   Lindenfeld, Joann ^b   Reddy, Vivek Y ^c   Hasenfuss, Gerd ^d   Kuck, Karl Heinz ^e   Boscardin, John ^f   Gibbons, Robert ^g   Burkhoff, Daniel ^h  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e DEPARTMENT OF CARDIOLOGY   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h Division of Cardiology Columbia University ^*  (United States)

Author keywords

cardiac resynchronization therapy; cardiopulmonary stress testing; Heart failure; quality of life

Indexed keywords

ADULT; ANAEROBIC THRESHOLD; ARTICLE; CARDIAC CONTRACTILITY MODULATION; COMPARATIVE STUDY; DEFIBRILLATOR; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART STIMULATION; HUMAN; IMPLANTABLE PULSE GENERATOR; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PATIENT SAFETY; PLACEBO EFFECT; PROSPECTIVE STUDY; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; VENTILATORY ANAEROBIC THRESHOLD; ADVERSE EFFECTS; CONTROLLED STUDY; FOLLOW UP; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STANDARDS; TREATMENT OUTCOME;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84919667441     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.09.011     Document Type: Article

References (26)

1. D. Burkhoff, and S.A. Ben Haim Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure Am J Physiol Heart Circ Physiol 288 2005 H2550 H2556
2. T. Lawo, M. Borggrefe, C. Butter, G. Hindricks, H. Schmidinger, and Y. Mika Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration J Am Coll Cardiol 46 2005 2229 2236
3. C.B. Brunckhorst, I. Shemer, Y. Mika, S.A. Ben Haim, and D. Burkhoff Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle Eur J Heart Fail 8 2006 7 15
4. M. Imai, S. Rastogi, R.C. Gupta, S. Mishra, V.G. Sharov, and W.C. Stanley Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure J Am Coll Cardiol 49 2007 2120 2128
5. C. Butter, S. Rastogi, H.H. Minden, J. Meyhofer, D. Burkhoff, and H.N. Sabbah Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure J Am Coll Cardiol 51 2008 1784 1789
6. C. Butter, E. Wellnhofer, M. Schlegl, G. Winbeck, E. Fleck, and H.N. Sabbah Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption J Card Fail 13 2007 137 142
7. M.M. Borggrefe, T. Lawo, C. Butter, H. Schmidinger, M. Lunati, and B. Pieske Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur Heart J 29 2008 1019 1028
8. S.B. Neelagaru, J.E. Sanchez, S.K. Lau, S.M. Greenberg, N.Y. Raval, and S. Worley Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration Heart Rhythm 3 2006 1140 1147
9. W.T. Abraham, D. Burkhoff, K. Nademanee, P. Carson, R. Bourge, and K.A. Ellenbogen A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics Am Heart J 156 2008 641 648
10. A. Kadish, K. Nademanee, K. Volosin, S. Krueger, S. Neelagaru, and N. Raval A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure Am Heart J 161 2011 329 337
11. W.T. Abraham, K. Nademanee, K. Volosin, S. Krueger, S. Neelagaru, and N. Raval Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure J Card Fail 17 2011 710 717
12. E.S. Chung, R.P. Katra, S. Ghio, J. Bax, B. Gerritse, and K. Hilpisch Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction >35%: a PROSPECT trial substudy Eur J Heart Fail 12 2010 581 587
13. J. Myers, R.L. Goldsmith, S.J. Keteyian, C.A. Brawner, D.A. Brazil, and H. Aldred The ventilatory anaerobic threshold in heart failure: a multicenter evaluation of reliability J Card Fail 16 2010 76 83
14. D. Burkhoff, M. Parides, M. Borggrefe, W.T. Abraham, and A. Kadish "Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance J Card Fail 15 2009 108 115
15. A.M. Russo, R.F. Stainback, S.R. Bailey, A.E. Epstein, P.A. Heidenreich, and M. Jessup ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Heart Rhythm 10 2013 e11 e58
16. D. Hedeker, and R.D. Gibbons Longitudinal data analysis 2006 Wiley New York
17. D. Rubin Inference and missing data Biometrika 63 1976 581 592
18. Guidance for the use of bayesian statistics in medical device clinical trials. Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm071072.htm. Accessed November 16, 2014.
19. G. Pennello, and L. Thompson Experience with reviewing bayesian medical device trials J Biopharm Stat 18 2008 81 115
20. D.J. Lunn, N. Best, A. Thomas, J. Wakefield, and D. Spiegelhalter Bayesian analysis of population PK/PD models: general concepts and software J Pharmacokinet Pharmacodyn 29 2002 271 307
21. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, and E. Loh Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
22. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, and T. De Marco Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
23. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, and L. Kappenberger Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
24. J.F. Beshai, R.A. Grimm, S.F. Nagueh, J.H. Baker 2nd, S.L. Beau, and S.M. Greenberg Cardiac-resynchronization therapy in heart failure with narrow QRS complexes N Engl J Med 357 2007 2461 2471
25. F. Ruschitzka, W.T. Abraham, J.P. Singh, J.J. Bax, J.S. Borer, and J. Brugada Cardiac-resynchronization therapy in heart failure with a narrow QRS complex N Engl J Med 369 2013 1395 1405
26. M. Borggrefe, and D. Burkhoff Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure Eur J Heart Fail 14 2012 703 712